Carla Araújo

Carla Araújo

Auto-generated profile, based on publicly available information

Carla Araújo

EPIUnit - Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2014 in Heart
Verified
Journal Article
Open access
PDF file
RARomain André
Romain André
VBVanina Bongard
Vanina Bongard
RERoberto Elosua
Roberto Elosua
IKInge Kirchberger
Inge Kirchberger
DFDimitrios Farmakis
Dimitrios Farmakis
JFJean Ferrières
Jean Ferrières
Objective We aimed to describe current characteristics of patients admitted for acute coronary syndrome (ACS) in Western Europe and to analyse whether international in-hospital mortality variations are explained by differences in patients’ baseline characteristics and in clinical management. Methods We studied a population-based longitudinal cohort conducted in Finland, France, Germany, Greece, Portugal and Spain, and comprising 12 231 consecutive ACS patients admitted in 53 hospitals between 2008 and 2010. Baseline characteristics, clinical management and inhospital outcomes were recorded. Contextual effect of country on death was analysed through multilevel analysis. Results Of all patients included, 8221 (67.2%) had NSTEMI (non-ST-elevation myocardial infarction), and 4010 (32.8%) had STEMI (ST-elevation myocardial infarction). Inhospital mortality ranged from 15.1% to 4.9% for German and Spanish STEMI patients, and from 6.8% to 1.9% for Finnish and French NSTEMI patients (p<0.001 for both). These international variations were explained by differences in patients’ baseline characteristics (older patients more likely to have cardiogenic shock in Germany) and in clinical management, with differences in rates of thrombolysis (less performed in Germany) and primary percutaneous coronary intervention (high in Germany, low in Greece). A remaining contextual effect of country was identified after extensive adjustment. Conclusions Inhospital mortality rates of STEMI and NSTEMI patients were two to three times higher in Finland, Germany and Portugal than in Greece and Spain, with intermediate values for France. Differences in baseline characteristics and clinical management partly explain differences in outcome. Our data also suggest an impact of the healthcare system organisation.

23 February 2018 in BMJ Open
Verified
Journal Article
Open access
PDF file
CACarla Araújo
Carla Araújo
OLOlga Laszczyńska
Olga Laszczyńska
MVMarta Viana
Marta Viana
FMFilipa Melão
Filipa Melão
AHAna Henriques
Ana Henriques
AAAna Azevedo
Ana Azevedo
Objectives Prompt diagnosis of acute coronary syndrome (ACS) remains a challenge, with presenting symptoms affecting the diagnosis algorithm and, consequently, management and outcomes. This study aimed to identify sex differences in presenting symptoms of ACS. Design Data were collected within a prospective cohort study (EPIHeart). Setting Patients with confirmed diagnosis of type 1 (primary spontaneous) ACS who were consecutively admitted to the Cardiology Department of two tertiary hospitals in Portugal between August 2013 and December 2014. Participants Presenting symptoms of 873 patients (227 women) were obtained through a face-to-face interview. Outcome measures: Typical pain was defined according to the definition of cardiology societies. Clusters of symptoms other than pain were identified by latent class analysis. Logistic regression was used to quantify differences in presentation of ACS symptoms by sex. Results Chest pain was reported by 82% of patients, with no differences in frequency or location between sexes. Women were more likely to feel pain with an intensity higher than 8/10 and this association was stronger for patients aged under 65 years (interaction P=0.028). Referred pain was also more likely in women, particularly pain referred to typical and atypical locations simultaneously. The multiple symptoms cluster, which was characterised by a high probability of presenting with all symptoms, was almost fourfold more prevalent in women (3.92, 95% CI 2.21 to 6.98). Presentation with this cluster was associated with a higher 30-day mortality rate adjusted for the GRACE V.2.0 risk score (4.9% vs 0.9% for the two other clusters, P<0.001). Conclusions While there are no significant differences in the frequency or location of pain between sexes, women are more likely to feel pain of higher intensity and to present with referred pain and symptoms other than pain. Knowledge of these ACS presentation profiles is important for health policy decisions and clinical practice.

1 May 2011 in European Journal of Gastroenterology & Hepatology
Verified
Journal Article
Closed access
RFRicardo Fontes-Carvalho
Ricardo Fontes-Carvalho
AAAníbal Albuquerque
Aníbal Albuquerque
CACarla Araújo
Carla Araújo
PPPedro Pimentel-Nunes
Pedro Pimentel-Nunes
VRVasco Gama Ribeiro
Vasco Gama Ribeiro
Proton pump inhibitors (PPIs) are usually prescribed to patients undergoing dual antiplatelet therapy to decrease the risk of gastrointestinal bleeding. Recent studies have raised concerns that PPIs could reduce clopidogrel's efficacy by competitive inhibition of cytochrome P450 2C19 isoenzyme. All PPIs are metabolized by cytochrome P450 2C19, although to varying degrees, and according to in-vitro studies, pantoprazole is the weakest inhibitor of this isoenzyme. We hypothesized that this drug interaction might not be a class effect. One month after an acute myocardial infarction 34 consecutive patients undergoing dual antiplatelet therapy were prospectively analyzed. Platelet function was measured (VerifyNow system), in each patient, in three consecutive clinical scenarios: (i) first, after a 1-month washout period, without any PPI, (ii) after a 4-week period taking omeprazole 40 mg, and (iii) after another 1-month washout period, followed by 4-weeks taking pantoprazole 40 mg. In this crossover trial, patients were first randomized to receive either omeprazole or pantoprazole. We observed a significant reduction in clopidogrel's effect when patients were initiated with omeprazole; the mean P2Y12 reaction units (PRU) increased from 202±52 to 235±58 with omeprazole (P240) but when patients started omeprazole, this proportion increased to 45 versus 23% with pantoprazole. In this randomized crossover study analyzing patients after acute myocardial infarction, omeprazole coadministration showed a significant pharmacodynamic interaction with clopidogrel, whereas pantoprazole did not. These data suggest that the clopidogrel–PPIs drug interaction may not be a class effect.

22 December 2017 in International Journal Of Clinical Practice
Verified
Journal Article
Closed access
PDF file
CACarla Araújo
Carla Araújo
MPMarta Pereira
Marta Pereira
OLOlga Laszczyńska
Olga Laszczyńska
PDPaula Dias
Paula Dias
AAAna Azevedo
Ana Azevedo

15 December 2011 in Drug and Alcohol Dependence
Verified
Journal Article
Closed access
CACarla Araújo
Carla Araújo
CSCarla Silva-Matos
Carla Silva-Matos
ADAlbertino Damasceno
Albertino Damasceno
MGMaria Lídia Gouveia
Maria Lídia Gouveia
AAAna Azevedo
Ana Azevedo
Nuno LunetNuno Lunet
Nuno Lunet

1 December 2016 in International Journal of Cardiology
Verified
Journal Article
Closed access
CACarla Araújo
Carla Araújo
MPMarta Pereira
Marta Pereira
MVMarta Viana
Marta Viana
OROlga Laszczyńska Rocha
Olga Laszczyńska Rocha
KBKathleen Bennett
Kathleen Bennett
AAAna Azevedo
Ana Azevedo